Joanna Weinstein

1.4k total citations
30 papers, 805 citations indexed

About

Joanna Weinstein is a scholar working on Ophthalmology, Molecular Biology and Genetics. According to data from OpenAlex, Joanna Weinstein has authored 30 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Joanna Weinstein's work include Ocular Oncology and Treatments (9 papers), Glioma Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Joanna Weinstein is often cited by papers focused on Ocular Oncology and Treatments (9 papers), Glioma Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Joanna Weinstein collaborates with scholars based in United States, Argentina and Egypt. Joanna Weinstein's co-authors include Susan L. Cohn, Howard M. Katzenstein, Jack Bleesing, Jodi Skiles, Jun Qin Mo, Kenneth L. McClain, Michael B. Jordan, Rebecca Marsh, Julie Kanter and Carl E. Allen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Joanna Weinstein

27 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Weinstein United States 14 241 237 227 226 143 30 805
Maarten Egeler Netherlands 11 258 1.1× 199 0.8× 291 1.3× 95 0.4× 87 0.6× 29 769
Kristin Zelley United States 15 181 0.8× 354 1.5× 153 0.7× 165 0.7× 114 0.8× 43 1.0k
Pascale Schneider France 14 252 1.0× 394 1.7× 113 0.5× 119 0.5× 46 0.3× 58 921
Mouhab Ayas Saudi Arabia 21 756 3.1× 316 1.3× 61 0.3× 196 0.9× 61 0.4× 92 1.3k
Jos P.M. Bökkerink Netherlands 21 218 0.9× 450 1.9× 437 1.9× 46 0.2× 66 0.5× 42 1.6k
Christiane Vermylen Belgium 20 568 2.4× 237 1.0× 39 0.2× 235 1.0× 97 0.7× 64 1.4k
H. Baurmann Germany 18 757 3.1× 180 0.8× 85 0.4× 215 1.0× 109 0.8× 61 1.2k
Jeffrey Davis Canada 17 441 1.8× 152 0.6× 78 0.3× 139 0.6× 23 0.2× 41 1.0k
Kleebsabai Sanpakit Thailand 13 256 1.1× 101 0.4× 40 0.2× 73 0.3× 104 0.7× 57 587
Aurora Medina‐Sansón Mexico 13 79 0.3× 141 0.6× 80 0.4× 59 0.3× 16 0.1× 40 665

Countries citing papers authored by Joanna Weinstein

Since Specialization
Citations

This map shows the geographic impact of Joanna Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Weinstein more than expected).

Fields of papers citing papers by Joanna Weinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Weinstein. The network helps show where Joanna Weinstein may publish in the future.

Co-authorship network of co-authors of Joanna Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Weinstein. A scholar is included among the top collaborators of Joanna Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Weinstein. Joanna Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Mi-Ra, Maureen Haugen, Elaine Morgan, et al.. (2025). Adherence to 6‐Mercaptopurine (6‐MP) and Habit Strength in Pediatric Acute Lymphoblastic Leukemia (ALL). European Journal Of Haematology. 114(5). 864–871.
2.
Goetsch, Allison L., et al.. (2023). Clinical utility of early rapid genome sequencing in the evaluation of patients with differences of sex development. American Journal of Medical Genetics Part A. 194(2). 351–357.
3.
Weinstein, Joanna, et al.. (2023). Leukemic Optic Neuropathy in Pediatric Patients: A Case Series. Journal of Pediatric Ophthalmology & Strabismus. 61(1). 67–72. 1 indexed citations
4.
Heneghan, Mallorie B., Leonardo Barrera, Maureen Haugen, et al.. (2021). Access to Technology and Preferences for an mHealth Intervention to Promote Medication Adherence in Pediatric Acute Lymphoblastic Leukemia: Approach Leveraging Behavior Change Techniques. Journal of Medical Internet Research. 23(2). e24893–e24893. 20 indexed citations
5.
Heneghan, Mallorie B., Leonardo Barrera, Maureen Haugen, et al.. (2020). Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer. 67(5). e28216–e28216. 20 indexed citations
6.
Dunkel, Ira J., Mark Krailo, Guillermo Chantada, et al.. (2017). Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321).. Journal of Clinical Oncology. 35(15_suppl). 10506–10506. 11 indexed citations
7.
Samet, Jonathan D., Joanna Weinstein, & Laura M. Fayad. (2016). MRI and clinical features of Langerhans cell histiocytosis (LCH) in the pelvis and extremities: can LCH really look like anything?. Skeletal Radiology. 45(5). 607–613. 17 indexed citations
8.
Lai, Jin‐Shei, et al.. (2016). A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients. Child s Nervous System. 32(3). 475–483. 10 indexed citations
9.
Fan, Hanli, Paul J. Bryar, Joanna Weinstein, et al.. (2015). Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation. PLoS ONE. 10(9). e0138366–e0138366. 32 indexed citations
10.
Fleming, Amy, et al.. (2015). Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies. Pediatric Blood & Cancer. 63(4). 723–726. 14 indexed citations
11.
Ryan, Maura E., et al.. (2014). Maternal to fetal transmission of cervical carcinoma. Pediatric Radiology. 44(8). 1035–1038. 7 indexed citations
12.
Bryar, Paul J., et al.. (2013). MicroRNAs-449a and -449b exhibit tumor suppressive effects in retinoblastoma. Biochemical and Biophysical Research Communications. 440(4). 599–603. 25 indexed citations
13.
Bryar, Paul J., Marilyn B. Mets, Joanna Weinstein, et al.. (2012). Differentially expressed miRNAs in retinoblastoma. Gene. 512(2). 294–299. 27 indexed citations
14.
Marsh, Rebecca, Carl E. Allen, Kenneth L. McClain, et al.. (2012). Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatric Blood & Cancer. 60(1). 101–109. 217 indexed citations
15.
Weinstein, Joanna, Kanyalakshmi Ayyanar, & Melody Watral. (2009). Secondary Neoplasms Following Treatment for Brain Tumors. Cancer treatment and research. 150. 239–273. 6 indexed citations
16.
Weinstein, Joanna, Kanyalakshmi Ayyanar, & Melody Watral. (2009). Cancer Predisposition Syndromes. Cancer treatment and research. 150. 223–238. 4 indexed citations
17.
Bryar, Paul J., et al.. (2009). Sudden Dispersion of Retinoblastoma Shortly after Initial Chemotherapy Treatment. American Journal of Ophthalmology. 147(5). 903–906. 5 indexed citations
18.
Rosenfeld, Amy, Morris Kletzel, David A. Jacobsohn, et al.. (2009). A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors. Journal of Neuro-Oncology. 97(2). 247–255. 17 indexed citations
19.
Zage, Peter E., Aaron J. Reitman, R. Seshadri, et al.. (2007). Outcomes of a two‐drug chemotherapy regimen for intraocular retinoblastoma. Pediatric Blood & Cancer. 50(3). 567–572. 22 indexed citations
20.
Bennett, C. L., Robert Golub, Elizabeth A. Calhoun, et al.. (1998). Cost-utility assessment of amifostine as first-line therapy for ovarian cancer. International Journal of Gynecological Cancer. 8(1). 64–72. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maarten Egeler Breakdown of academic impact, for papers by Kristin Zelley Breakdown of academic impact, for papers by Pascale Schneider Breakdown of academic impact, for papers by Mouhab Ayas Breakdown of academic impact, for papers by Jos P.M. Bökkerink Breakdown of academic impact, for papers by Christiane Vermylen Breakdown of academic impact, for papers by H. Baurmann Breakdown of academic impact, for papers by Jeffrey Davis Breakdown of academic impact, for papers by Kleebsabai Sanpakit Breakdown of academic impact, for papers by Aurora Medina‐Sansón
Rankless by CCL
2026